117 related articles for article (PubMed ID: 29928787)
1. Molecular causes of elevated phosphoethanolamine in breast and pancreatic cancer cells.
Shah T; Krishnamachary B; Wildes F; Wijnen JP; Glunde K; Bhujwalla ZM
NMR Biomed; 2018 Aug; 31(8):e3936. PubMed ID: 29928787
[TBL] [Abstract][Full Text] [Related]
2. Lipid metabolism in T47D human breast cancer cells: 31P and 13C-NMR studies of choline and ethanolamine uptake.
Ronen SM; Rushkin E; Degani H
Biochim Biophys Acta; 1991 Oct; 1095(1):5-16. PubMed ID: 1657190
[TBL] [Abstract][Full Text] [Related]
3. Choline kinase-α protein and phosphatidylcholine but not phosphocholine are required for breast cancer cell survival.
Mori N; Wildes F; Kakkad S; Jacob D; Solaiyappan M; Glunde K; Bhujwalla ZM
NMR Biomed; 2015 Dec; 28(12):1697-706. PubMed ID: 26503172
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive detection of lentiviral-mediated choline kinase targeting in a human breast cancer xenograft.
Krishnamachary B; Glunde K; Wildes F; Mori N; Takagi T; Raman V; Bhujwalla ZM
Cancer Res; 2009 Apr; 69(8):3464-71. PubMed ID: 19336572
[TBL] [Abstract][Full Text] [Related]
5. Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells.
Mori N; Glunde K; Takagi T; Raman V; Bhujwalla ZM
Cancer Res; 2007 Dec; 67(23):11284-90. PubMed ID: 18056454
[TBL] [Abstract][Full Text] [Related]
6. Lipid metabolism in large T47D human breast cancer spheroids: 31P- and 13C-NMR studies of choline and ethanolamine uptake.
Ronen SM; Rushkin E; Degani H
Biochim Biophys Acta; 1992 Mar; 1138(3):203-12. PubMed ID: 1547282
[TBL] [Abstract][Full Text] [Related]
7. Interplay of choline metabolites and genes in patient-derived breast cancer xenografts.
Grinde MT; Skrbo N; Moestue SA; Rødland EA; Borgan E; Kristian A; Sitter B; Bathen TF; Børresen-Dale AL; Mælandsmo GM; Engebraaten O; Sørlie T; Marangoni E; Gribbestad IS
Breast Cancer Res; 2014 Jan; 16(1):R5. PubMed ID: 24447408
[TBL] [Abstract][Full Text] [Related]
8. Characterization of choline kinase in human endothelial cells.
Mori N; Gadiya M; Wildes F; Krishnamachary B; Glunde K; Bhujwalla ZM
NMR Biomed; 2013 Nov; 26(11):1501-7. PubMed ID: 23775813
[TBL] [Abstract][Full Text] [Related]
9. Response of choline metabolites to docetaxel therapy is quantified in vivo by localized (31)P MRS of human breast cancer xenografts and in vitro by high-resolution (31)P NMR spectroscopy of cell extracts.
Morse DL; Raghunand N; Sadarangani P; Murthi S; Job C; Day S; Howison C; Gillies RJ
Magn Reson Med; 2007 Aug; 58(2):270-80. PubMed ID: 17654590
[TBL] [Abstract][Full Text] [Related]
10. Phospholipase D1 and choline kinase-α are interactive targets in breast cancer.
Gadiya M; Mori N; Cao MD; Mironchik Y; Kakkad S; Gribbestad IS; Glunde K; Krishnamachary B; Bhujwalla ZM
Cancer Biol Ther; 2014 May; 15(5):593-601. PubMed ID: 24556997
[TBL] [Abstract][Full Text] [Related]
11. Quantitative (31)P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts.
Esmaeili M; Bathen TF; Engebråten O; Mælandsmo GM; Gribbestad IS; Moestue SA
Magn Reson Med; 2014 Jun; 71(6):1973-81. PubMed ID: 23878023
[TBL] [Abstract][Full Text] [Related]
12. Targeting choline phospholipid metabolism: GDPD5 and GDPD6 silencing decrease breast cancer cell proliferation, migration, and invasion.
Cao MD; Cheng M; Rizwan A; Jiang L; Krishnamachary B; Bhujwalla ZM; Bathen TF; Glunde K
NMR Biomed; 2016 Aug; 29(8):1098-107. PubMed ID: 27356959
[TBL] [Abstract][Full Text] [Related]
13. Choline kinase overexpression increases invasiveness and drug resistance of human breast cancer cells.
Shah T; Wildes F; Penet MF; Winnard PT; Glunde K; Artemov D; Ackerstaff E; Gimi B; Kakkad S; Raman V; Bhujwalla ZM
NMR Biomed; 2010 Jul; 23(6):633-42. PubMed ID: 20623626
[TBL] [Abstract][Full Text] [Related]
14. Exposure of human breast cancer cells to the anti-inflammatory agent indomethacin alters choline phospholipid metabolites and Nm23 expression.
Natarajan K; Mori N; Artemov D; Bhujwalla ZM
Neoplasia; 2002; 4(5):409-16. PubMed ID: 12192599
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
[TBL] [Abstract][Full Text] [Related]
16. RGD-modified oncolytic adenovirus-harboring shPKM2 exhibits a potent cytotoxic effect in pancreatic cancer via autophagy inhibition and apoptosis promotion.
Xu Y; Chu L; Yuan S; Yang Y; Yang Y; Xu B; Zhang K; Liu XY; Wang R; Fang L; Chen Z; Liang Z
Cell Death Dis; 2017 Jun; 8(6):e2835. PubMed ID: 28569774
[TBL] [Abstract][Full Text] [Related]
17. A comparison of in vivo and in vitro 31P NMR spectra from human breast tumours: variations in phospholipid metabolism.
Smith TA; Glaholm J; Leach MO; Machin L; Collins DJ; Payne GS; McCready VR
Br J Cancer; 1991 Apr; 63(4):514-6. PubMed ID: 2021535
[TBL] [Abstract][Full Text] [Related]
18. Silencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivo.
Zhou J; Song S; He S; Wang Z; Zhang B; Li D; Zhu D
Int J Mol Med; 2013 Sep; 32(3):653-60. PubMed ID: 23846297
[TBL] [Abstract][Full Text] [Related]
19. Silencing the Metallothionein-2A gene induces entosis in adherent MCF-7 breast cancer cells.
Lai Y; Lim D; Tan PH; Leung TK; Yip GW; Bay BH
Anat Rec (Hoboken); 2010 Oct; 293(10):1685-91. PubMed ID: 20652934
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of CDK4 impairs proliferation of pancreatic cancer cells and sensitizes towards TRAIL-induced apoptosis via downregulation of survivin.
Retzer-Lidl M; Schmid RM; Schneider G
Int J Cancer; 2007 Jul; 121(1):66-75. PubMed ID: 17304504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
